STAAR Surgical Q4: Ongoing Challenges In China Masks Healthy Growth Elsewhere

STAAR Surgical (NASDAQ: STAA ) announced Q4 results where Q4 revenue of $49 million was down 36% year over year, and well below management's guidance of$ 77 million. While global revenue ex-China grew strongly by 17% year over year, revenueAn individual investor primarily focused on undercovered companies, with more than 50 companies on my watchlist. My areas include technology, software, electronics and the energy transition. I have been investing my personal capital for over 7 years in a broad range of co ...